Non-Small Cell Lung Cancer Stage IIIA
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Non-Small Cell Lung Cancer Stage IIIA?
There are 1 clinical trial targeting Non-Small Cell Lung Cancer Stage IIIA tracked by BioSniper.
What is the prevalence of Non-Small Cell Lung Cancer Stage IIIA?
The estimated prevalence of Non-Small Cell Lung Cancer Stage IIIA is approximately 30.0 per 100,000 population.
Deep-dive into Non-Small Cell Lung Cancer Stage IIIA
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis